News about OPRX

On October 21, 2026, OptimizeRx (NASDAQ:OPRX), a healthcare technology company offering digital health and communication solutions, closed at $9.37 with a $176.49 million market cap, down 23.57% year to date. In its Q3 2026 investor letter, White Brook Capital said the stock is recovering after a round trip in its share price, as drug makers cut spending and signed shorter contracts in response to the Most Favored Nation drug-pricing policy. Although one large client stopped purchases this year, management kept its profit forecast, refinanced debt at a lower rate, and saw spending grow from smaller clients it added. Management expects disruption from the Trump administration's pricing and tariff policies to continue through year-end, followed by a significantly better 2027.